DE69930952D1 - Gesteuerte freisetzung von antidepressiva - Google Patents

Gesteuerte freisetzung von antidepressiva

Info

Publication number
DE69930952D1
DE69930952D1 DE69930952T DE69930952T DE69930952D1 DE 69930952 D1 DE69930952 D1 DE 69930952D1 DE 69930952 T DE69930952 T DE 69930952T DE 69930952 T DE69930952 T DE 69930952T DE 69930952 D1 DE69930952 D1 DE 69930952D1
Authority
DE
Germany
Prior art keywords
release
antidepressiva
taxed
triazolones
antidepressants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69930952T
Other languages
English (en)
Other versions
DE69930952T2 (de
Inventor
G Cruz
Noymi Yam
Adam Zhong
Atul Ayer
Padmanabh Bhatt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69930952D1 publication Critical patent/DE69930952D1/de
Application granted granted Critical
Publication of DE69930952T2 publication Critical patent/DE69930952T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
DE69930952T 1998-11-02 1999-10-26 Verfahren und Vorrichtung zur kontrollierten Abgabe pharmazeutischer Mittel sowie Dosierungsform hierfür Expired - Lifetime DE69930952T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10675898P 1998-11-02 1998-11-02
US10667798P 1998-11-02 1998-11-02
US106758P 1998-11-02
US106677P 1998-11-02
PCT/US1999/025017 WO2000025790A1 (en) 1998-11-02 1999-10-26 Controlled delivery of antidepressants

Publications (2)

Publication Number Publication Date
DE69930952D1 true DE69930952D1 (de) 2006-05-24
DE69930952T2 DE69930952T2 (de) 2006-08-31

Family

ID=26803899

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69930952T Expired - Lifetime DE69930952T2 (de) 1998-11-02 1999-10-26 Verfahren und Vorrichtung zur kontrollierten Abgabe pharmazeutischer Mittel sowie Dosierungsform hierfür

Country Status (13)

Country Link
EP (1) EP1126853B1 (de)
JP (1) JP4711510B2 (de)
KR (2) KR100734193B1 (de)
AT (1) ATE323493T1 (de)
AU (1) AU1230800A (de)
CA (1) CA2349719C (de)
CY (1) CY1105463T1 (de)
DE (1) DE69930952T2 (de)
DK (1) DK1126853T3 (de)
ES (1) ES2260962T3 (de)
HK (1) HK1038515A1 (de)
PT (1) PT1126853E (de)
WO (1) WO2000025790A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1539115E (pt) * 2002-07-29 2008-01-14 Alza Corp Métodos e formas de dosagem para libertação controlada de paliperidona
AU2003256848A1 (en) * 2002-07-29 2004-02-16 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
AU2004275835B2 (en) * 2003-09-26 2011-06-23 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
MXPA06003450A (es) 2003-09-26 2006-08-31 Johnson & Johnson Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
CN101703488B (zh) * 2008-12-16 2013-02-20 北京科信必成医药科技发展有限公司 具有润滑层结构的双层渗透泵控释片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082668A (en) * 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
ATE173613T1 (de) * 1993-08-31 1998-12-15 Alza Corp Behälter, der ein hydrophober arzneimittel enthält
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
DE69725345T2 (de) * 1996-02-15 2004-08-19 Janssen Pharmaceutica N.V. Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden
WO1997047285A1 (en) * 1996-06-10 1997-12-18 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form

Also Published As

Publication number Publication date
CY1105463T1 (el) 2010-04-28
ES2260962T3 (es) 2006-11-01
EP1126853B1 (de) 2006-04-19
JP2002528505A (ja) 2002-09-03
AU1230800A (en) 2000-05-22
JP4711510B2 (ja) 2011-06-29
KR20010075677A (ko) 2001-08-09
HK1038515A1 (en) 2002-03-22
WO2000025790A1 (en) 2000-05-11
CA2349719C (en) 2009-06-02
KR100734193B1 (ko) 2007-07-02
DK1126853T3 (da) 2006-08-14
EP1126853A1 (de) 2001-08-29
PT1126853E (pt) 2006-07-31
ATE323493T1 (de) 2006-05-15
KR20070040421A (ko) 2007-04-16
DE69930952T2 (de) 2006-08-31
CA2349719A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
RS49685B (sr) Novi oblik jedinjenja
EE200100293A (et) Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
ES2114487B1 (es) Mezcla estabilizante sinergistica.
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
FR2694182B1 (fr) Attache pour prothèse, notamment interpédiculaire.
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
ZA977695B (en) 1,4-heterocyclic metalloprotease inhibitors.
ID18189A (id) Dervat-derivat 6,6-hetero-bisiklik yang disubstitusi
ZA97927B (en) New substituted oxazolidinones.
FI913215A (fi) Additionspolymeriseringskatalysator, som aktiveras medelst oxidering.
RS50071B (sr) Novi oblik soli pantoprazola
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
CY1105463T1 (el) Ελεγχομενη χορηγηση αντικαταθλιπτικων
ATE288909T1 (de) Indolderivate verwendbar zur behandlung von u.a. osteoporosis
FI920080A0 (fi) Kulfaongare, som uppstannar kulor.
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.
BR0101437A (pt) Método para preparar um ciclopropeno
UA32598C2 (uk) Спосіб одержання лікарської форми карбамазепіну
DE69426021T2 (de) Xamonelin-Tartrat
IL127930A0 (en) Verapamil as a medicament for the treatment of angina
SE9404438D0 (sv) New process
FR2689026B1 (fr) Chevillere, notamment pour le sport.
FR2670116B1 (fr) Electrode, notamment electrode temporaire pour le cóoeur.
NO920793L (no) Krummet, tapt nettverksforskaling, spesielt for foring avutboringer i stenformasjoner o.l.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition